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Heparin interacts with protein kinases in various ways; the different patterns of behavior of heparin towards 
protein kinases contributes to the characterization of these enzymes. We studied the interactions between 
heparin and a new type of tyrosine kinase extracted from the normal human red cell membrane. We found 
that heparin inhibited kinase activity by competition with ATP. Furthermore the interaction of heparin with 
the red cell membrane tyrosine kinase allowed us to use heparin-agarose chromatography as a step towards 
tyrosine kinase purification. 
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1. INTRODUCTION 
Heparin, a sulfated mucopolysaccharide, is a 
multifunctional molecule able to form a complex 
with many proteins and enzymes, and change the 
properties of these substances [l]. It has been 
found that heparin modifies the activity of some 
protein kinases. It inhibits casein kinase II from 
various origins [2-41 and phospholipid-sensitive 
Ca’+-dependent protein kinase from heart [5]; it 
stimulates the phosphorylation of some protein 
substrates by CAMP-dependent protein kinase [6]. 
However other kinases such as casein kinase I 
17,813 rat liver poly(A) polymerase activating 
tyrosine kinase [9] and tyrosine kinase from Rous 
sarcoma virus (pp60STC) [lo] are insensitive to 
heparin. 
Recently we extracted and partially purified a 
new type of tyrosine kinase from the membrane of 
normal human red blood cell [ 111; its physiological 
substrate is the cytosolic fragment (FB3) of protein 
Abbreviations: PMSF, phenylmethylsulfonyl fluoride; 
Mes, 2-(IV-morpholino)ethanesulfonic acid; BME, p- 
mercaptoethanol; FB3, cytosolic fragment of membrane 
protein band 3 (43 kDa peptide) 
3, the principal transmembrane protein [12]. The 
properties of this kinase distinguish it clearly from 
those of the insulin receptor. 
Here, we studied the interaction of heparin with 
the red cell membrane tyrosine kinase: we show 
that heparin is an inhibitor of enzyme activity by 
competition with ATP and that interaction be- 
tween heparin and enzyme may be used for the 
purification of this tyrosine kinase. 
2. MATERIALS AND METHODS 
2.1. Extraction of tyrosine kinase 
The method of extraction and partial purifica- 
tion of red cell membrane tyrosine kinase will be 
reported in detail elsewhere. Briefly, ghosts from 
normal volunteer adults were prepared according 
to Dodge et al. [13] in 5 mM phosphate buffer (pH 
8) + 0.1 mM PMSF. White ghosts were washed 
once in 25 mM Hepes buffer (pH 7.6) + 0.1 mM 
PMSF + 0.1 mM BME and 0.1 mM EDTA (buffer 
A), and then extracted twice with 1% Triton X-100 
and 1% Nonidet P40 in buffer A for 1 h at 0°C 
with gentle stirring; after centrifugation the super- 
natant which contains the insulin receptor and a 
part of the membrane tyrosine kinase activity was 
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discarded. The pellet was then extracted with one 
third of the initial volume of ghosts of 0.25 M 
NaCl in buffer A for 1 h at 0°C then centrifuged 
at 20000 rpm for 30 min. The supernatant was 
used as enzyme source for further purification 
(‘crude extract’). 
Partial purification was obtained by 
phosphocellulose chromatography. 25 ml crude 
extract were dialyzed overnight against 1000 ml 
buffer A + 0.1% Nonidet and 0.1% Triton X-100 
(buffer B) and then poured onto the 
phosphocellulose column (10 x 1 cm) previously 
equilibrated with the same buffer. Elution was ob- 
tained with a NaCl gradient from 0.25 to 1 M; 
tyrosine kinase eluted in a single peak at 0.53 M 
NaCl with a yield of about 50%. 
2.2. Enzyme activity assay 
Enzyme activity was assayed with FB3 as 
substrate. This fragment was purified according to 
Bennett and Stenbuck [ 141. 
In standard assays enzyme activity was assayed 
in 25 mM Mes buffer (pH 6.5) in the presence of 
5 mM MnC12,O. 1 mM PMSF, 0.1 mM EDTA and 
5 PM [T-~~P]ATP with amounts of substrate cor- 
responding to 0.5 mg/ml final concentration and 
10 ~1 enzyme source in a total volume of 20 ~1. The 
mixture was incubated at 0°C for 30 min, and the 
reaction was stopped by trichloroacetic acid 
precipitation as previously reported [IS]. The en- 
zyme activity was expressed as pmol 32P trans- 
ferred to the substrate under the experimental con- 
ditions (OOC, 30 min). In some experiments a syn- 
thetic substrate [poly(Glu Na,Ala,Tyr), 6 : 3 : 1, 
Sigma] was substituted for the 43 kDa peptide. 
3. RESULTS 
3.1. Inhibition of tyrosine kinase by heparin 
Increasing concentrations of heparin, from 1 to 
100 pg/ml (final concentration), were added to the 
reaction mixture. Inhibition was almost complete 
for concentrations higher than lOpg/ml and 50% 
inhibition was observed at 2.5 pg/ml. Inhibition 
was also observed with the synthetic peptide, 50% 
inhibition being obtained for a heparin concentra- 
tion of lOpg/ml (fig.1). 
3.2. Study of inhibition mechanism 
Interaction between the FB3 substrate and 
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Fig. 1. Inhibition curves of tyrosine kinase activity with 
respect to heparin concentrations from 1 to 50pg/ml 
(final concentration) using FB3 (o---o) or 
poly(Glu Na,Ala,Tyr) (A---A) as substrate. 
heparin was investigated by determining the reac- 
tion rate at 4 different heparin concentrations 
from 0 to lOpg/ml in the presence of an ATP 
saturating concentration (5 PM) and 4 different 
FB3 peptide concentrations (0.465-4.64 PM). The 
Lineweaver-Burk plot revealed a constant K, and 
a variable Vmax indicating that heparin was a non- 
competitive inhibitor with respect to FB3 peptide 
(fig.2A). 
Interaction of heparin with ATP was studied in 
the presence of constant FB3 level (0.45 mg/ml in 
final concentration) at 4 different ATP concentra- 
tions from 0.125 to 1 PM (final concentration) and 
4 different heparin concentrations from 0 to 
6 pg/ml. The Lineweaver-Burk plot showed a con- 
stant Vmax and different K,,, indicating that heparin 
acted as a competitive inhibitor with respect to 
ATP (fig.2B). 
3.3. Chromatography of tyrosine kinase on 
heparin-agarose (Heparin-Ultrogel A4R, 
Industrie Biologique Francaise) 
A little column (1 x 4 cm) was filled with 
heparin-ultrogel and equilibrated with buffer B. It 
was loaded with 25 ml crude extract previously 
dialyzed as above, washed out with buffer B and 
then eluted with an NaCl concentration gradient 
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Fig.2. (A) Lineweaver-Burk plot of initial rate as 
function of FB3 concentration at 5 pM ATP. Heparin: 
(0) 0, (m) 3pg/ml, (A) 5pg/ml, (*) lOgg/ml. (B) 
Lineweaver-Burk plot of initial rate as function of ATP 
concentration at FB3 concentration 0.45 mg/ml. 
Heparin: (0) 0, ( n ) 3 pg/ml, (A) 5 pug/ml, (*) 6 pg/ml. 
from 0 to 0.7 M in the same buffer. Tyrosine 
kinase activity eluted in an unique peak at 0.36 M 
NaCl with a chromatographic yield of about 60% 
(fig.3A). 
4. DISCUSSION 
Interactions of heparin with protein kinase dif- 
fer from one enzyme to another and their study 
contributes towards enzyme identification. In this 
field, the most extensively studied protein kinases 
are casein kinases. Heparin inhibition clearly 
distinguishes casein kinase I which is not sensitive 
to heparin from casein kinase II which is inhibited 
[7-161. Moreover, the determination of the inhibi- 
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Fig.3. Comparison of purification profile. (-) 
Tyrosine kinase activity, (---) proteins. (A) On 
heparin-agarose; specific activity of enzyme active 
fraction no.19: 3.9 nM 32P per mg protein. (B) On 
phosphocellulose; specific activity of enzyme active 
fraction no.32: 2.7 nM 32P per mg protein. 
tion mechanisms allows for the further separation 
of enzymes sharing similar origin or properties. 
For instance, heparin is a competitive inhibitor 
with respect to casein for a casein kinase from rab- 
bit reticulocytes [2] while it acts as a non- 
competitive inhibitor with respect to both 
substrates ATP and casein for the human 
erythrocyte cytosolic casein kinase [7]. 
Until now little was known about the interaction 
of heparin with protein tyrosine kinases and pro- 
tein kinases C. Concerning the tyrosine kinases, 
Ito et al. [lo] noticed that heparin did not modify 
91 
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the vinculin phosphorylation by the pp60’” 
tyrosine kinase, and Stetler et al. [9] that a tyrosine 
kinase activating the rat liver poly(A) polymerase 
was insensitive to heparin. 
Affinity chromatography on heparin bound to 
Sepharose or agarose was used by several authors 
to purify the estrogen receptor of calf uterus 
[ 17,181 and rat liver glucocorticoid receptor [19]. 
This latter is an endogenous protein kinase [20,21]. 
However, the action of heparin on enzyme activity 
was not reported. 
Our work demonstrates that heparin-agarose 
may ,be used instead of phosphocellulose in the 
course of some tyrosine kinase purification. 
Probably heparin acts as a cation exchanger by its 
sulfate groups rather than as a real affinity 
support. 
Arguments in favor of the use of heparin- 
agarose are the easy handling, the brief duration 
and good yield of chromatography and the conve- 
nient separation power similar to that of 
phosphocellulose (fig.3B). 
5. CONCLUSION 
This study of the interaction of heparin with the 
human red cell membrane tyrosine kinase leads to 
the following conclusions: (i) Heparin is an in- 
hibitor of enzyme activity by competition with 
ATP. This property contributes towards the iden- 
tification of the red cell membrane tyrosine kinase 
with respect o other tyrosine kinases. (ii) Interac- 
tion of heparin with the red cell membrane tyrosine 
kinase may be used for the purification of this 
enzyme. 
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